COVID 19 is caused by Severe Acute Respiratory Syndrome Corona Virus-2 which results in wide range of manifestations. Systemic hypercoagulation is a typical feature of COVID-19. We present a case of COVID-19 in whom TEG was performed on admission and hypercoagulability was diagnosed and hence patient was started on Enoxaparin sodium 6000 IU twice daily. TEG was repeated after 5 days which showed normal coagulation status and the patient was discharged without any thrombotic complications.
CITATION STYLE
Vaidya, A., Paonam, B., Mohan, G., & Shastry, S. (2022). Illustration: Thromboelastography - A useful tool to monitor COVID-19-associated coagulopathy. Asian Journal of Transfusion Science, 16(1), 148–149. https://doi.org/10.4103/ajts.ajts_73_21
Mendeley helps you to discover research relevant for your work.